Ross Muken
Stock Analyst at Evercore ISI Group
(1.59)
# 2,234
Out of 4,479 analysts
24
Total ratings
64.71%
Success rate
8.21%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: In-Line | $145 → $126 | $127.48 | -1.16% | 9 | May 30, 2024 | |
| ICLR ICON PLC | Maintains: Outperform | $350 → $330 | $318.64 | +3.57% | 3 | Apr 26, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $79 → $83 | $65.70 | +26.34% | 3 | Feb 28, 2024 | |
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $265 | $203.74 | +30.07% | 3 | Feb 15, 2024 | |
| CAH Cardinal Health | Initiates: In-Line | n/a | $96.43 | - | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | n/a | $107.23 | - | 2 | Jan 4, 2018 | |
| QGEN Qiagen | Initiates: Outperform | $36 | $40.46 | -10.89% | 1 | Jan 4, 2018 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $537.93 | - | 1 | Jan 4, 2018 |
Agilent Technologies
May 30, 2024
Maintains: In-Line
Price Target: $145 → $126
Current: $127.48
Upside: -1.16%
ICON PLC
Apr 26, 2024
Maintains: Outperform
Price Target: $350 → $330
Current: $318.64
Upside: +3.57%
Henry Schein
Feb 28, 2024
Maintains: In-Line
Price Target: $79 → $83
Current: $65.70
Upside: +26.34%
Charles River Laboratories International
Feb 15, 2024
Maintains: Outperform
Price Target: $260 → $265
Current: $203.74
Upside: +30.07%
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: n/a
Current: $96.43
Upside: -
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: n/a
Current: $107.23
Upside: -
Qiagen
Jan 4, 2018
Initiates: Outperform
Price Target: $36
Current: $40.46
Upside: -10.89%
Thermo Fisher
Jan 4, 2018
Initiates: Outperform
Price Target: n/a
Current: $537.93
Upside: -